|
Volumn 145, Issue 4, 2006, Pages 310-312
|
Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant [3]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
LIVER ENZYME;
PEGVISOMANT;
SOMATOMEDIN C;
DRUG DERIVATIVE;
HUMAN GROWTH HORMONE;
ABDOMINAL DISTENSION;
ACROMEGALY;
ADIPOSE TISSUE;
ADULT;
ANTHROPOMETRY;
CASE REPORT;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
DRUG EFFICACY;
ECHOGRAPHY;
FEMALE;
HUMAN;
LETTER;
LIPOHYPERTROPHY;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
WAIST CIRCUMFERENCE;
WAIST HIP RATIO;
ABDOMEN;
CHEMICALLY INDUCED DISORDER;
HYPERTROPHY;
LIPODYSTROPHY;
PATHOLOGY;
SUBCUTANEOUS DRUG ADMINISTRATION;
ABDOMEN;
ACROMEGALY;
ADIPOSE TISSUE;
ADULT;
FEMALE;
HUMAN GROWTH HORMONE;
HUMANS;
HYPERTROPHY;
INJECTIONS, SUBCUTANEOUS;
LIPODYSTROPHY;
MALE;
|
EID: 33747100659
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-145-4-200608150-00017 Document Type: Letter |
Times cited : (29)
|
References (5)
|